BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20656766)

  • 1. The psychological impact of genital herpes stigma.
    Merin A; Pachankis JE
    J Health Psychol; 2011 Jan; 16(1):80-90. PubMed ID: 20656766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living with a concealable stigmatized identity: the impact of anticipated stigma, centrality, salience, and cultural stigma on psychological distress and health.
    Quinn DM; Chaudoir SR
    J Pers Soc Psychol; 2009 Oct; 97(4):634-51. PubMed ID: 19785483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disclosure processes model: understanding disclosure decision making and postdisclosure outcomes among people living with a concealable stigmatized identity.
    Chaudoir SR; Fisher JD
    Psychol Bull; 2010 Mar; 136(2):236-56. PubMed ID: 20192562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to: Impact of primary and recurrent genital herpes on the quality of life of young people and adults: a mixed methods systematic review.
    JBI Evid Synth; 2024 Jun; 22(6):1205. PubMed ID: 38862463
    [No Abstract]   [Full Text] [Related]  

  • 5. "Discredited" Versus "Discreditable": Understanding How Shared and Unique Stigma Mechanisms Affect Psychological and Physical Health Disparities.
    Chaudoir SR; Earnshaw VA; Andel S
    Basic Appl Soc Psych; 2013 Jan; 35(1):75-87. PubMed ID: 23729948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
    Schulte JM; Bellamy AR; Hook EW; Bernstein DI; Levin MJ; Leone PA; Sokol-Anderson ML; Ewell MG; Wolff PA; Heineman TC; Belshe RB
    South Med J; 2014 Feb; 107(2):79-84. PubMed ID: 24926671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
    Bradley H; Markowitz LE; Gibson T; McQuillan GM
    J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological and psychosexual implications of herpes simplex virus infections.
    Mindel A
    Scand J Infect Dis Suppl; 1996; 100():27-32. PubMed ID: 9163020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital Herpes: A Review.
    Groves MJ
    Am Fam Physician; 2016 Jun; 93(11):928-34. PubMed ID: 27281837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
    Seyfizadeh N; Kalbermatter D; Imhof T; Ries M; Müller C; Jenner L; Blumenschein E; Yendrzheyevskiy A; Grün F; Moog K; Eckert D; Engel R; Diebolder P; Chami M; Krauss J; Schaller T; Arndt M
    J Biomed Sci; 2024 May; 31(1):56. PubMed ID: 38807208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study.
    Silva S; Ayoub HH; Johnston C; Atun R; Abu-Raddad LJ
    PLoS Med; 2022 Dec; 19(12):e1003938. PubMed ID: 36520853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in individuals with genital herpes: a systematic review.
    Devine A; Xiong X; Gottlieb SL; de Mello MB; Fairley CK; Ong JJ
    Health Qual Life Outcomes; 2022 Feb; 20(1):25. PubMed ID: 35172828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological health and well-being in patients with sexually transmitted infections: A prospective cross-sectional study.
    Singh S; Singh SK
    Indian J Sex Transm Dis AIDS; 2021; 42(2):125-131. PubMed ID: 34909616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial.
    Van Wagoner N; Fife K; Leone PA; Bernstein DI; Warren T; Panther L; Novak RM; Beigi R; Kriesel J; Tyring S; Koltun W; Lucksinger G; Morris A; Zhang B; McNeil LK; Tasker S; Hetherington S; Wald A
    J Infect Dis; 2018 Nov; 218(12):1890-1899. PubMed ID: 29982727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital herpes stigma: Toward the Measurement and Validation of a highly prevalent yet hidden public health problem.
    Wang K; Merin A; Rendina HJ; Pachankis JE
    Stigma Health; 2018 Feb; 3(1):27-34. PubMed ID: 29629409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus 1 and 2 educational assessment of young adults in rural southwest Virginia.
    Hover SS; Bertke AS
    PLoS One; 2017; 12(6):e0179969. PubMed ID: 28654651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes.
    Borschuk AP; Everhart RS; Eakin MN; Rand-Giovannetti D; Borrelli B; Riekert KA
    J Cyst Fibros; 2016 Sep; 15(5):696-702. PubMed ID: 26996270
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.